This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Phillips-Medisize Corp. representatives Bill Welch, Chief Technology Officer, and Janne Turunen, Program Manager, will be part of the Sanofi presentation at the Partnership Opportunities in Drug Delivery (PODD) in Boston, Masachusetts on October 5, 2015.
The PODD conference brings together leaders in the pharma/biotech industry for networking and presentation on the latest drug delivery technologies, as well as insights on delivery and formulation needs. The ultimate goal of the conference is to inspire innovation and advancement of drug development and delivery.
"We're pleased to join Paul Jansen from Sanofi, along with Rob Veasey of DCA Design International, at the PODD session entitled 'The SoloStar Injection Device: Foundation for a Versatile Platform.' At Phillips-Medisize, our team of 450 engineers is actively engaged in the design, development, and commercialization of a wide range of drug delivery platforms, from injector pens to inhalation devices to wearable infusers, all in partnership with leading global phiopharma companies," said Bill Welch.
The PODD conference will use the Intercontinental Boston hotel as its venue this year and Phillips-Medisize representatives will be available inthe exhibit hall at Booth 46.
